This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Jiuzhitang Co., Ltd., Mudanjiang Youbo Pharmaceutical Co., Ltd.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Yunnan, CN (2018 - 2019)
- Kunming, CN (2020)
Company Filing History:
Years Active: 2018-2025
Title: Innovations by Na Gao in Antithrombotic Research
Introduction
Na Gao is a prominent inventor based in Yunnan, China, known for his significant contributions to the field of antithrombotic research. With a total of four patents to his name, Gao has focused on developing innovative compounds that can inhibit intrinsic coagulation factors, thereby providing new avenues for treating thrombotic diseases.
Latest Patents
Gao's latest patents include an oligosaccharide compound designed to inhibit the intrinsic coagulation factor X-enzyme complex. This purified oligosaccharide compound exhibits antithrombotic activity and can be used in pharmaceutical compositions aimed at preventing and treating thrombotic diseases. Another notable patent is for a Fuc3S4S substituted oligoglycosaminoglycan, which has a weight-average molecular weight of about 4.5-9 kD. This compound also has applications in the preparation of medicines for thrombotic disease prevention and treatment.
Career Highlights
Throughout his career, Na Gao has worked with reputable companies such as Jiuzhitang Co., Ltd. and Mudanjiang Youbo Pharmaceutical Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the development of effective therapeutic solutions.
Collaborations
Gao has collaborated with notable colleagues, including Jinhua Zhao and Mingyi Wu, to further enhance his research efforts and expand the impact of his innovations in the pharmaceutical field.
Conclusion
Na Gao's innovative work in the development of antithrombotic compounds showcases his dedication to advancing medical science and improving treatment options for thrombotic diseases. His contributions are significant in the ongoing fight against these health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile